By Narendra N. Tandon, Christian F. Ockenhouse, Nicholas J. Greco, and G.A. Jamieson Glycoprotein IV (GPIV; CD36 or GPlllb) is a cell surface glycoprotein that has been proposed as mediating a number of physiologically important processes such as the adhesion of platelets to thrombospondin (TSP) and collagen, the cytoadherence of Plasmodium falciparum-infected erythrocytes, and the TSP-dependent interaction of monocytes with platelets and macrophages. Because platelets of the Nak'-negative phenotype have recently been shown to lack detectable GPIV, their availability offered the opportunity to test directly these hypotheses regarding its adhesive functions. It LYCOPROTEIN IV (GPIV, Mr 88,000) is a major G membrane glycoprotein that has been shown to be identical with the differentiation antigen CD36' and is found in a wide range of cells and tissues including platelets, endothelial cells, melanoma cells, hematopoietic cell lines, and mammary epithelial GPIV from platelets has been purified and partially sequenced3 and its full primary sequence has been determined from a placental cDNA? It has been shown to meet the criteria for a collagen receptor6 and to support cytoadherence of erythrocytes infected with Plasmodium fakiparum malaria.' .' GPIV has also been proposed as being the thrombospondin (TSP) receptor in platelets9.'* and tumor cells'3 and in mediating platelet-monocyte and monocyte-macrophage interact i o n~. '~ We have recently shown that blood platelets of the Nap-negative phenotype do not express GPIV,I5 although they do contain the corresponding mRNA.I6 This phenotype is present in -3% of the Japanese p~pulation'~ and -0.3% of the US pop~lation.'~ While these individuals are apparently healthy and suffer no obvious hematologic or other problems as a result of the absence of GPIV, they are at risk for developing isoantibodies after infusion of Nappositive platelet^.'^ We have now used Nap-negative platelets and monocytes to evaluate the adhesive functions of GPIV in its reaction with collagen, TSP, and red blood cells (RBC) infected with P fulcipumm malaria.
G membrane glycoprotein that has been shown to be identical with the differentiation antigen CD36' and is found in a wide range of cells and tissues including platelets, endothelial cells, melanoma cells, hematopoietic cell lines, and mammary epithelial GPIV from platelets has been purified and partially sequenced3 and its full primary sequence has been determined from a placental cDNA? It has been shown to meet the criteria for a collagen receptor6 and to support cytoadherence of erythrocytes infected with Plasmodium fakiparum malaria.' .' GPIV has also been proposed as being the thrombospondin (TSP) receptor in platelets9.'* and tumor cells'3 and in mediating platelet-monocyte and monocyte-macrophage interact i o n~. '~ We have recently shown that blood platelets of the Nap-negative phenotype do not express GPIV,I5 although they do contain the corresponding mRNA.I6 This phenotype is present in -3% of the Japanese p~pulation'~ and -0.3% of the US pop~lation.'~ While these individuals are apparently healthy and suffer no obvious hematologic or other problems as a result of the absence of GPIV, they are at risk for developing isoantibodies after infusion of Nappositive platelet^.'^ We have now used Nap-negative platelets and monocytes to evaluate the adhesive functions of GPIV in its reaction with collagen, TSP, and red blood cells (RBC) infected with P fulcipumm malaria.
MATERIALS AND METHODS

Reagents. The anti-TSP monoclonal antibody (MoAb) 5 G l l was kindly provided by Dr Chantal Legrand (INSERM, Hopital
Lariboisiere, Paris, France) and the anti-GPIV MoAbs OKM-5 and OKM-8 by Dr Patricia Rao (Ortho Diagnostic Systems, Inc, Raritan, NJ). cy-Thrombin (2,900 U/mg) was prepared as described.I8 GPIV was purified under nondenaturing conditions by phase partitioning in Triton X-114 followed by chromatography on diethyl aminoethyl-cellulose and wheat germ agglutinin-Sepharose, as previously de~cribed.'.~ At this stage, GPIV was 95% pure as assessed by silver staining and it migrated on sodium dodecyl sulfate-polyacrylamide gel electrophoresis with molecular weight 88 Kd under both reducing and nonreducing conditions.
Whole blood (50 mL) was collected from the Nap-negative donor (ARC-36)" or from control laboratory staff into citratephosphate-dextrose-adenine anticoagulant (7 mL). Platelet-rich plasma was obtained by centrifugation at 20% for 10 minutes. Platelets were citrate-washed in the presence of prostaglandin E, and diluted to a final concentration of 2 to 4 x 10' cells/mL has been found that Nak'-negative platelets and monocytes do not support cytoadherence of Pfalciparum-infected erythrocytes. Nak'-negative platelets are deficient in the initial stages of their adhesion to fibrillar collagen and this defect is most marked under Mg"-free conditions. Finally, the ability of Nak'megative platelets to bind TSP before or after activation is unimpaired as compared with normal controls. These results do not support a role for GPIV as the TSP receptor. 0 1991 by The American Society of Hematology.
(Coulter Electronics, Hialeah, FL) depending on the type of experiment in which they were to be used.
When required, platelets (2 x lo' mL) were labeled with Na;'CrO, (50 FCi/mL) (Amersham Corp, 250 mCi/mg) for 1 hour at 37°C in adhesion buffer followed by washing with citrate wash buffer containing 0.5% bovine serum albumin.'' The specific activity was -1,000 cpm/106 platelets. Prostaglandin E, (50 ng/ mL) was present during all washing and labeling procedures.
Divalent cation-free buffer was prepared by passing 10 mmol/L Tris.HC1, pH 7.35, 140 mmol/L NaC1, 5.5 mmol/L glucose over Chelex-100 as described by the manufacturer (Bio-Rad, Richmond, CA) or by the addition of 100 kmol/L EDTA to chelate trace amounts of divalent cations present in the reagents and water. Because adhesion was identical in either buffer, most experiments on M$-independent platelet adhesion were studied using buffers containing 100 pmol/L EDTA.
Washed "Cr-labeled platelets were prepared in divalent cationfree buffer containing 100 pmol/L EDTA or in adhesion buffer containing 2 mmol/L Mg2' and adhesion to type 1 fibrillar collagen was measured in microtiter plates as previously described. 6 In the present experiments, nonadhered platelets were removed from the microtiter dishes by decantation and gentle washing (six times) with Tris-buffered saline to avoid loss of bound platelets due to shear forces generated by aspiration at the water pump.
Purified GPIV' was adsorbed to plastic Petri dishes (Falcon 1007; Becton Dickinson, Lincoln Park, NJ) overnight at 4°C and nonspecific binding sites were then blocked by incubating with 1% bovine serum albumin in phosphate-buffered saline for 30 minutes at room temperature. IRBC of the ItG strain selected for adhesiveness to CD36' (0.5% hematocrit, 25% parasitemia) were added to the plates and incubated for 30 minutes. After washing to remove unbound erythrocytes, control or Nap-negative platelets were added to each culture dish at 1 x 108/mL. After 30 minutes, the plates were gently rinsed with RPMI 1640, fixed with 2% glutaraldehyde, and stained with Giemsa. At least 500 IRBC were use only.
For personal at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From counted to determine the mean percentage of IRBC binding one or more platelets as well as the total number of platelets bound per 500 IRBC.
GPIV expression on human monocytes was assessed by the immunogold silver staining method (Auroprobe; Amersham, Arlington, IL). Human monocytes were isolated by adherence to 12-mm round glass coverslips. Anti-GPIV MoAbs, OKM-5 and OKM-8, were added (5 pg/mL) for 30 minutes at room temperature. The coverslips were washed three times and colloidal goldconjugated goat anti-mouse antibodies (1:40) were added and allowed to react for 30 minutes. The cells were fixed with ice-cold methanol-acetone (1:l) and the silver enhancement reagents provided by the manufacturer were added to amplify the immunostaining of human monocytes by anti-GPIV antibodies. The cells were lightly counterstained with Giemsa and examined under light microscopy for blue-black precipitates characteristic of a positive reaction for the presence of surface-expressed GPIV.
For studies on the adhesion of IRBC to monocytes, mononuclear cells were isolated from whole blood by centrifugation on FicollHypaque (Pharmacia, Piscataway, NJ) at 1,50$ for 30 minutes at room temperature. The mononuclear cells were washed with RPMI-1640 and suspended to 1 x lo6 cells/mL in RPMI-1640 supplemented with 10% human serum and incubated in 24-well tissue culture plates at 37°C in 7.5% CO,. After 90 minutes, nonattached cells were removed by washing three times and IRBC were added (400 pL/well; 20% parasitemia; 2.5% hematocrit) and allowed to stand for 60 minutes. Unattached erythrocytes were removed, cells were fixed with 1.25% glutaraldehyde, stained with Giemsa, and the number of IRBC bound per 100 monocytes was quantitated by light microscopy. 
TIME OF ADHESION [MINUTES]
5 G l l concentration was 40 pg/mL. In experiments with OKM5, platelets were incubated with the antibody for 10 minutes without shaking before the addition of a-thrombin.
RESULTS
Platelets adhere to collagen by divalent cation-dependent and divalent cationindependent mechanisms.*' The divalent cation-independent process has usually been studied in the presence of high concentrations of EDTA (2 to 5 mmol/L) and using aspiration at the water pump to remove supernatant fluid and unattached platelets: under these conditions adhesion has been found to be about 5% of that occurring in the presence of 2 mmol/L free Mg2+. Because high concentrations of EDTA can affect the integrity of the platelet membrane we have, in the present work, studied divalent cation-independent adhesion in the presence of buffers lacking free M$+ and Ca2' and in the presence of only very low concentrations of EDTA (100 pmol/L). We have also used decantation to avoid the loss of weakly attached platelets due to shear forces generated by the aspiration process. Under these conditions, divalent cation-independent adhesion of control platelets was about one third of the adhesion observed in the presence of 2 mmol/L Mg2+ (Fig 1) . When NaK-negative platelets were examined under the divalent cation-independent protocol (Fig lA) , adhesion was significantly less than that seen with control platelets at the earliest timepoint examined (7.5 minutes, P < .009) and this reduced adhesion was apparent up to 60 minutes of interaction with the collagen substrate (P < .013), but adhesion was not significantly different by 90 minutes of incubation. Even in the presence of 2 mmol/L Mg2+ the mean adhesion of Naka-negative platelets was less than that of control platelets at 7.5 minutes (P < .008) and use only.
For personal at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From 15 minutes (P < .04), but the difference was not statistically significant beyond this point. Under both divalent cation-dependent and divalent cation-independent protocols, serotonin secretion paralleled adhesion for both control and Nap-negative platelets. No differences between Nap-positive and Nap-negative platelets were observed in the time course of adhesion to laminin and fibronectin (data not shown).
The cytoadherence of P falciparurn-infected RBC is thought to be due to GPIV present in endothelial cells, platelets, and monocyte^.^ GPIV is absent from Naka-negative platelets" and we could not detect expression of GPIV in the monocytes of this donor using the colloidal gold technique. Table 1 describes the interaction of Nap-negative platelets and monocytes with IRBC. The results show that Nap-negative platelets gave values that were only 1% to 2% of control platelets in terms of the number of IRBC binding one or more platelets per 500 IRBC examined and in the total number of platelets bound. A similar deficiency was seen in the number of IRBC bound per 100 monocytes. In parallel experiments, uninfected erythrocytes did not bind to platelets or monocytes from control or Naka-negative donors (not shown).
The binding of the TSP, as measured by the binding of lZ5I-5Gll, was identical in control and Nap-negative platelets both in the resting state and after stimulation with two different concentrations of highly purified human a-thrombin ( Table 2 ). The addition of the anti-GPIV antibody OKM-5 (2.5 pg/mL) did not significantly affect the amount of TSP bound to resting control or Nap-negative platelets, but reduced by 60% the thrombininducible binding of TSP in control platelets while no such reduction was observed in Nap-negative platelets.
Cytoadherence of ZRBC.
Binding of TSP.
DISCUSSION
We have previously shown, using two different protocols, that anti-GPIV polyclonal Fab fragments show their greatest effect in inhibiting the Mg"-dependent adhesion of normal platelets to collagen during the first 10 minutes of the adhesive process.6 These observations are confirmed by the present studies that show a statistically significant reduction in the adhesion of Nap-negative platelets during the first 15 minutes. Adhesion was consistently less in Nap-negative platelets as compared with controls at all timepoints up to 60 minutes, but these reductions were not statistically significant.
Platelets can also adhere to collagen under divalent cation-independent conditions." These conditions have usually been achieved by adding relatively high concentrations (2 to 5 mmol/L) of EDTA or EGTA to the platelet Binding of TSP was measured using 1251-labeled 5 G l l MoAb and highly purified human a-thrombin. In experiments with OKM-5, the antibody was incubated with the platelets for 10 minutes without shaking before addition of a-thrombin. In control experiments, 2.5 pg of mouse IgG had no effect. Three separate samples were studied from the Nak"-negative donor and four different donors were used for the control (Nak'-positive) platelets and each time duplicate determinations were performed.
suspension, but the adhesion observed was only about 5% of that seen in the presence of divalent cations. Because these concentrations of chelating agents can have deleterious effects on the structure and function of membrane components, we performed our studies using buffers prepared in the absence of divalent cations and containing very low concentrations of EDTA (100 kmol/L) as well as using decantation to avoid the shear stresses induced by aspiration at the water pump. Under these conditions, adhesion is about one third of divalent cation-dependent adhesion. Under these conditions, statistically significant decrements in the adhesion of Nap-negative platelets were seen up to 60 minutes.
Seven criteria have been proposed to establish the role of putative collagen receptors for platelets.6.'' Our previous studies6 showed that GPIV met five of these criteria and the present work shows that it meets the sixth; namely, that receptor-associated defects should be identifiable in the platelets of patients with specific defects in adhesion. The present studies show that under both divalent cationdependent and divalent cation-independent conditions the initial rate of adhesion to collagen is reduced in Napnegative platelets but that the number of adherent platelets ultimately becomes equal in control and Nap-negative samples. Moreover, it may be noted that the rate of adhesion of control platelets is markedly biphasic in the absence of 2 mmol/L Mg'+ with a breakpoint at 15 minutes while the response of Nap-negative platelets is curvilinear over the same time period (Fig 1A) . The reason for these rate differences is not known. GPIV (CD36) in platelets has recently been shown to be associated with at least three use only.
For personal at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From src-related protein tyrosine kinases" and the phosphorylation processes associated with these may serve to accelerate adhesion in control platelets. The physiologic significance of the GPIV-dependent component of adhesion has not yet been established. All of the Nap-negative individuals so far identified have self-selected as young, healthy blood donors so that we do not know the long-term prognosis nor whether there are disease associations. It is intriguing to speculate that the reduced response of Nap-negative platelets to collagen might actually have a protective effect against such conditions as atherosclerosis.
The absence of GPIV in Nap-negative platelets completely ablates their ability to interact with P falcipamminfected erythrocytes. This was also the case with Napnegative monocytes, which we have now shown also lack GPIV. These results confirm the importance of GPIV in mediating the cytoadherence of IRBC.
The third adhesive function ascribed to GPIV is as the TSP receptor in platelets, monocytes, and tumor cell^.^-'^ Therefore, we expected that Nap-negative platelets would show reduced ability to bind TSP. However, the amounts of TSP bound to Nap-negative platelets were identical with the amounts bound to control (Naka-positive) platelets both in the resting state and after stimulation with two concentrations of a-thrombin. We confirmed previous reports that MoAbs against GPIV such as OKM-5 would inhibit TSP binding in activated control (Nap-positive) platelets, but we found that OKM-5 did not inhibit the binding of TSP to activated Nap-negative platelets. Activation and secretion induced by OKM-5 in control platelets has previously been reportedz and we have found that OKM-5 did not induce detectable serotonin release from Nap-negative platelets at OKM-5 concentrations of 1.25 Fg/mL, indicating that this effect is mediated through GPIV (data not shown).
These results show that GPIV is not the TSP receptor on platelets and that the immunoinhibition of TSP binding in control platelets probably arises because anti-GPIV antibodies such at OKM-5 sterically occlude access of TSP to its receptor which, therefore, may be in close proximity to GPIV. It may be noted that the binding of TSP to nonactivated platelets, as measured with the anti-TSP MoAb 5Gl1, is not inhibited by OKM-5 while binding to thrombin-activated platelets is inhibited. This may suggest that there are differences between the constitutive and inducible TSP receptors in platelets.
The present studies with Nap-negative platelets and monocytes, which lack GPIV, confirm and extend previous observations regarding its adhesive functions in the interaction of platelets with collagen and the cytoadherence of P falcipamm-infected erythrocytes. They provide unequivocal evidence that GPIV is not the inducible TSP receptor and explain previous studies that have questioned the relationship of TSP to GPIV?,24.26 They suggest that, while the TSP receptor is distinct from GPIV, it is in such close proximity that access to it can be blocked by anti-GPIV antibodies.
